CASI PHARMACEUTICALS, INC. Operating Lease, Expense
CASI PHARMACEUTICALS, INC. (CASIF) reported Operating Lease, Expense of $1.30 million for the 12-month period ending 2022-12-31, per its 20-F filed 2023-04-26.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2023-04-26
| Period end | Operating Lease, Expense 12 month |
|---|---|
| 2022-12-31 | $1.30M 20-F · filed 2023-04-26 |
| 2021-12-31 | $1.50M 20-F · filed 2023-04-26 |
| 2020-12-31 | $1.60M 20-F · filed 2023-04-26 |